3041B |
Metoclopramide, Blood |
3041SP |
Metoclopramide, Serum/Plasma |
3041U |
Metoclopramide, Urine |
3055B |
Mexiletine, Blood |
3055SP |
Mexiletine, Serum/Plasma |
3092SP |
Moricizine, Serum/Plasma |
3227B |
Beta-Blockers Panel, Blood |
3227SP |
Beta-Blockers Panel, Serum/Plasma |
3227U |
Beta-Blockers Panel, Urine |
3232B |
Omeprazole / Esomeprazole, Blood |
3232SP |
Omeprazole / Esomeprazole, Serum/Plasma |
3426B |
Perfluorooctanoic Acid, Blood Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3427SP |
Perfluoroalkyl Substances (PFAS), Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3428SP |
PFASure TM, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3429SP |
PFASure TM Expanded, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3752B |
Phosphatidylethanol, Blood |
3975B |
Propanol, n-, Blood |
3975SP |
Propanol, n-, Serum/Plasma |
3975U |
Propanol, n-, Urine |
3976B |
Propafenone, Blood |
3976SP |
Propafenone, Serum/Plasma |